Yuji Shimura

1.2k citations

69 papers · 704 indexed · h-index 15

Impact in

Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment

Papers in

Hematology 33
- Multiple Myeloma Research and Treatments 16
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 6
Pathology and Forensic Medicine 35
- Lymphoma Diagnosis and Treatment 31

Co-authors: Junya Kuroda Masafumi Taniwaki Tsutomu Kobayashi Shigeo Horiike Hisao Nagoshi Yoshiaki Chinen Yosuke Matsumoto Shinsuke Mizutani
Journals: International Journal of Hematology (10 papers)Infection and Drug Resistance (5 papers)British Journal of Haematology (3 papers)Experimental Hematology (3 papers)Cancer Medicine (3 papers)
Partner nations: Japan United States Australia

In The Last Decade

Yuji Shimura

63 papers receiving 696 citations

Peers

Countries citing papers authored by Yuji Shimura

Since Specialization

Citations

This map shows the geographic impact of Yuji Shimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Shimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Shimura more than expected).

Fields of papers citing papers by Yuji Shimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Shimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Shimura. The network helps show where Yuji Shimura may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuji Shimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuji Shimura Line = papers co-authored together Yuji Shimura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma Hematological Oncology ·Dong Mi, Long-Fei Cong, Judi Steel, Musyanovych Rostyslav Ya., John R. Bartolomew, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Satoshi Teramukai, Junya Kuroda	2024	6
2	Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities Leukemia ·Long-Fei Cong, Shinsuke Mizutani, Taku Tsukamoto, Gregory M. Hemenway, S H Preston, Musyanovych Rostyslav Ya., Paul Newbury, 郇雷, Takahiro Fujino, Yuji Shimura, K. Ichikawa, Junya Kuroda	2024	1
3	Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin’s Lymphoma Cureus ·Akio Onishi, Paul Newbury, Yuji Shimura, Jéssica Habr Tavares, Takahiro Fujino, Shinsuke Mizutani, Taku Tsukamoto, Yukiko Shishido‐Hara, Junya Kuroda	2023	0
4	Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms Infection and Drug Resistance ·Akio Onishi, E Bunk, Shinsuke Mizutani, Taku Tsukamoto, Takahiro Fujino, Judi Steel, Madeline Jubran, Kazuho Shimura, Hiroto Kaneko, Eri Kawata, Ryoichi Takahashi, Tsutomu Kobayashi, Hitoji Uchiyama, Nobuhiko Uoshima, Yoko Nukui, Yuji Shimura, Tohru Inaba, Junya Kuroda	2023	3
5	miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma Cancer Science ·S H Preston, Taku Tsukamoto, Masakazu Nakano, Nobuharu Saitoh, Hiroaki Nagata, Musyanovych Rostyslav Ya., Gregory M. Hemenway, 郇雷, Takahiro Fujino, E Bunk, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Kei Tashiro, Junya Kuroda	2023	3
6	Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature Infection and Drug Resistance ·Linda Stiglica, Paul Newbury, Hiroaki Nagata, Long-Fei Cong, Akio Onishi, 喜一山崎, 郇雷, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Fabiana Estrella-Enriquez, Tohru Inaba, Yoko Nukui, Junya Kuroda	2022	1
7	Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study Cancer Medicine ·Musyanovych Rostyslav Ya., Tsutomu Kobayashi, Mitsushige Nakao, Ryoichi Takahashi, Hiroto Kaneko, Kazuho Shimura, AlHazzani A.A., Nobuhiko Uoshima, Katsuya Wada, Eri Kawata, 郇雷, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Abigail Taron, Akihide Watanabe, Chie Sotozono, Junya Kuroda	2022	4
8	Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma Diagnostics ·Long-Fei Cong, Nobuhiko Uoshima, Paul Newbury, 郇雷, Takahiro Fujino, E Bunk, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Eri Kawata, Hitoji Uchiyama, Junya Kuroda	2021	5
9	Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities Experimental Hematology ·Yoshiaki Chinen, Taku Tsukamoto, Abdul Qader Al-Housan, E Bunk, آرزو ایزی, Nádia Shirley Correia Sobral Soares, Ilda D'Anessa, 広岡慶治, Lin Chih-Wen, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda	2020	4
10	<p>Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib</p> Infection and Drug Resistance ·Ali Ahmad Al-Shar, Yoshiaki Chinen, Taku Tsukamoto, آرزو ایزی, Lin Chih-Wen, E Bunk, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Junya Kuroda	2020	2
11	Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline Cancer Genomics & Proteomics ·آرزو ایزی, Hisao Nagoshi, Chris Tierman, 広岡慶治, Taku Tsukamoto, E Bunk, Ilda D'Anessa, Yoshiaki Chinen, Shinsuke Mizutani, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Tsutomu Kobayashi, Junya Kuroda	2018	10
12	Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma Cancer Research ·Yoshiaki Chinen, Junya Kuroda, Yuji Shimura, Hisao Nagoshi, Miki Kiyota, Mio Yamamoto‐Sugitani, Shinsuke Mizutani, Natsumi Sakamoto, Masaki Ri, Eri Kawata, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Shinsuke Iida, Masafumi Taniwaki	2014	28
13	Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents International Journal of Hematology ·(unknown), Junya Kuroda, Yuji Shimura, Kensuke Ohta, Hirokazu Tanaka, Hirohiko Shibayama, Satoru Kosugi, Shin‐ichi Fuchida, Masayuki Kobayashi, Hitomi Kaneko, Nobuhiko Uoshima, Kazuyoshi� Ishii, Shosaku� Nomura, Masafumi Taniwaki, Akifumi Takaori‐Kondo, Chihiro Shimazaki, Mitsuru Tsudo, Masayuki Hino, Itaru Matsumura, Yuzuru Kanakura	2014	10
14	Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome Case Reports in Oncology ·Yuji Shimura, Junya Kuroda, Nana Sasaki, Hitoji Uchiyama, Pettness Furusa, Yasushi Horibe, Hisao Nagoshi, Shinsuke Mizutani, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki	2014	0
15	Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation International Journal of Hematology ·Yoshiaki Chinen, Junya Kuroda, Pettness Furusa, Yuji Shimura, Shinsuke Mizutani, Hisao Nagoshi, Nana Sasaki, Shuning Tang, Miki Kiyota, Mio Yamamoto‐Sugitani, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki	2013	5
16	FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors APOPTOSIS ·Miki Kiyota, Junya Kuroda, Mio Yamamoto‐Sugitani, Yuji Shimura, Shuning Tang, Hisao Nagoshi, Shinsuke Mizutani, Yoshiaki Chinen, Nana Sasaki, Natsumi Sakamoto, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki	2013	29
17	Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma Expert Review of Anticancer Therapy ·Junya Kuroda, Hisao Nagoshi, Yuji Shimura, Masafumi Taniwaki	2013	12
18	RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma Molecular Cancer Therapeutics ·Yuji Shimura, Junya Kuroda, Masaki Ri, Hisao Nagoshi, Mio Yamamoto‐Sugitani, Tsutomu Kobayashi, Miki Kiyota, Shuning Tang, Shinsuke Mizutani, Yoshiaki Chinen, Natsumi Sakamoto, Yosuke Matsumoto, Shigeo Horiike, Yukimasa Shiotsu, Shinsuke Iida, Masafumi Taniwaki	2012	28
19	Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia Molecular Cancer Research ·Junya Kuroda, Pavlo Horishnii, Hisao Nagoshi, Tsutomu Kobayashi, Nana Sasaki, Yuji Shimura, Shigeo Horiike, Shinya Kimura, Akira Yamauchi, Хаджиева Марет Вахаева, Masafumi Taniwaki	2010	61
20	A CASE OF ILEAL DUPLICATION PRESENTED AS ACUTE PERITONITIS Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Yuji Shimura, Masato Kano, http://lattes.cnpq.br/6185801009606543, Diana Locke, Stercz Balazs, 灏兴	2008	2

About Yuji Shimura

Yuji Shimura is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Immunology, having authored 69 papers that have together received 704 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (31 papers), Multiple Myeloma Research and Treatments (16 papers), Viral-associated cancers and disorders (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), Protein Degradation and Inhibitors (11 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (227 citations), Pathology and Forensic Medicine (199 citations), Genetics (100 citations), Immunology (190 citations) and Oncology (226 citations). Yuji Shimura has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Junya Kuroda, Masafumi Taniwaki, Tsutomu Kobayashi, Shigeo Horiike, Hisao Nagoshi, Yoshiaki Chinen, Yosuke Matsumoto, Shinsuke Mizutani, Nana Sasaki and Miki Kiyota. Their work appears in journals such as International Journal of Hematology, Infection and Drug Resistance, British Journal of Haematology, Experimental Hematology and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact